Growing numbers of U.S. adults and children are experiencing a new kind of pain — a growing and often painful chronic condition called muscle growth medicine.
It’s also one of the fastest-growing medical markets in the world, and has generated a flurry of new treatments and therapies, from stem cells to a new generation of painkillers.
In a wide-ranging interview with CBC News, Dr. Peter Soderberg, chief medical officer for the American College of Emergency Physicians, said he doesn’t see an indication of a slowdown in growth medicine’s growth in this country.
In fact, he said, it is accelerating.
“I would say it’s going to accelerate,” Soderheim said.
“It’s really just one of those things that is going to continue to go on and on.
I think you’ll see more and more of it.”
According to the latest data from the American Society of Hematology and Oncology, there were nearly 8 million new patients in the U.K. last year, an increase of 8.4 per cent over the previous year.
That’s compared to 7.7 million in the previous five years.
“The growth is really unprecedented, and it’s happening in a relatively short period of time,” said Dr. Matthew Brown, the head of emergency medicine at University of Southern California.
Brown noted that some of the growth is in the younger, older patients that are going through some of these issues, and he thinks it’s a good thing for the country as a whole.
“I think we’re going to see a significant increase in the use of these drugs in the future, and hopefully they’ll be able to help people in other areas,” Brown said.
There are also many more people in this new population who have chronic pain, and the more of them that are able to get those medications and the greater their quality of life, the better off they’ll feel, Brown added.
Soderheim pointed out that the United Kingdom has been seeing growth in its overall population, which was 4 per cent last year.
That’s more than the U of S. saw last year and is on track to exceed the U S. population growth rate of about 2.5 per cent.
Sederheim also noted that the U s growth in patients with chronic pain has been in tandem with the country’s general population growth.
That is, more and better-educated people tend to be healthier, and are more likely to be getting more medical care.
“So I think the population is going up, but it’s still a bit of a plateau,” he said.
Sobering growth has been taking place in some areas of the country, with some states seeing a dramatic spike in painkiller prescriptions, while others are seeing a decrease.
For example, New York state saw a 33 per cent jump in prescriptions for painkillers in 2018, while California saw a 9 per cent drop.
“In the state of Texas, we had an increase in prescriptions of the analgesics in general in 2018,” Brown noted.
But for many of these patients, they are in pain because of a problem that they have had for a long time.
Brown said it’s possible that the growth in growth-related painkiller usage is a temporary blip.
“We have seen an increase over the past five years in the numbers of people who are seeking medical care for chronic pain,” he added.
“For the vast majority of people, that’s the main concern, but we have seen that over time.”
Soderberg said growth in painkillers has been accompanied by a growth in prescription drugs, which are not only more expensive, but also require more tests.
That has led to a shift from treating the patients themselves, and getting a doctor’s prescription, to getting a prescription from a drugstore or online.
“That is a really bad idea,” Sederheim said, noting that it’s very hard to make good decisions with that kind of risk.
“There’s a lot of pressure on doctors to get their drugs on the shelves.”
The U. S. is still the leader in medical marijuana use, and is the only country in the developed world to allow recreational use.
Somer is not the first person to see the growing pains of this new phenomenon.
In 2010, U.N. expert Dr. Michael Fauci described a growing number of people in the developing world suffering from severe, chronic pain and asking whether there were signs of growing muscle.
He noted that while many people were happy with the legal availability of marijuana, many felt there was an underlying psychological issue that led to the addiction.
“A lot of these people are people with a history of psychological trauma, and they are looking for help,” Fauce said at the time.
Fauce’s research found that cannabis was associated with reduced levels of the neurotransmitter dopamine, which is important in the reward system.
He also found that when people were prescribed the drug